Active, Not Recruiting
Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
NCT05987423
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
- Locations
-
- Thrive Health Research LLC Beverly Hills, California, United States
- UCSD Shiley Eye Center La Jolla, California, United States
- Grene Vision Group, LLC Wichita, Kansas, United States
- Johns Hopkins University Baltimore, Maryland, United States